BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8510231)

  • 1. Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation.
    Hilfinger JM; Clark N; Smith M; Robinson K; Markovitz DM
    J Virol; 1993 Jul; 67(7):4448-53. PubMed ID: 8510231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.
    Clark NM; Smith MJ; Hilfinger JM; Markovitz DM
    J Virol; 1993 Sep; 67(9):5522-8. PubMed ID: 8350410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.
    Clark NM; Hannibal MC; Markovitz DM
    J Virol; 1995 Aug; 69(8):4854-62. PubMed ID: 7609053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.
    Markovitz DM; Smith MJ; Hilfinger J; Hannibal MC; Petryniak B; Nabel GJ
    J Virol; 1992 Sep; 66(9):5479-84. PubMed ID: 1501284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.
    Fu GK; Markovitz DM
    J Biol Chem; 1996 Aug; 271(32):19599-605. PubMed ID: 8702655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
    Chan YJ; Chiou CJ; Huang Q; Hayward GS
    J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.
    Leiden JM; Wang CY; Petryniak B; Markovitz DM; Nabel GJ; Thompson CB
    J Virol; 1992 Oct; 66(10):5890-7. PubMed ID: 1527846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
    Thompson CB; Wang CY; Ho IC; Bohjanen PR; Petryniak B; June CH; Miesfeldt S; Zhang L; Nabel GJ; Karpinski B
    Mol Cell Biol; 1992 Mar; 12(3):1043-53. PubMed ID: 1545787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1).
    Zhang DE; Fujioka K; Hetherington CJ; Shapiro LH; Chen HM; Look AT; Tenen DG
    Mol Cell Biol; 1994 Dec; 14(12):8085-95. PubMed ID: 7969146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cis-acting elements in the human immunodeficiency virus type 2 enhancer mediate the response to T-cell receptor stimulation by antigen in a T-cell hybridoma line.
    Hannibal MC; Markovitz DM; Nabel GJ
    Blood; 1994 Apr; 83(7):1839-46. PubMed ID: 8142652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.
    Roulston A; Beauparlant P; Rice N; Hiscott J
    J Virol; 1993 Sep; 67(9):5235-46. PubMed ID: 8394446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.
    Griffin GE; Leung K; Folks TM; Kunkel S; Nabel GJ
    Nature; 1989 May; 339(6219):70-3. PubMed ID: 2654643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
    Mufson RA; Myers C; Turpin JA; Meltzer M
    J Leukoc Biol; 1992 Dec; 52(6):637-44. PubMed ID: 1464736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer.
    Henkel G; Brown MA
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7737-41. PubMed ID: 8052653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phorbol ester response element within the human T-cell receptor beta-chain enhancer.
    Prosser HM; Wotton D; Gegonne A; Ghysdael J; Wang S; Speck NA; Owen MJ
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9934-8. PubMed ID: 1409722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.
    Demarchi F; D'Agaro P; Falaschi A; Giacca M
    J Virol; 1993 Dec; 67(12):7450-60. PubMed ID: 8230466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
    Sun W; Graves BJ; Speck NA
    J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function.
    Grant PA; Thompson CB; Pettersson S
    EMBO J; 1995 Sep; 14(18):4501-13. PubMed ID: 7556093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte maturation controls expression of equine infectious anemia virus.
    Maury W
    J Virol; 1994 Oct; 68(10):6270-9. PubMed ID: 8083967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.